P75.03 KEYNOTE-U01: A Phase 2 Umbrella Study of Investigational Agents Plus Pembrolizumab-Based Therapy for Advanced NSCLC

Autor: Rao, S., Arnold, S., Carbone, D., Salgia, R., Tsao, A., Niu, J., Aggarwal, C., Dragnev, K.H., Awad, M., Gainor, J., Gubens, M., Velcheti, V., Telliho, L., Akala, O.O., Chartash, E., Stevenson, J.
Zdroj: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S573-S573
Databáze: ScienceDirect